Theratechnologies Resumes EGRIFTA SV® Production

Theratechnologies (TSE:TH) has released an update.

Theratechnologies has resumed production of its EGRIFTA SV® following a temporary shutdown to address FDA inspection observations. The company is managing its inventory to meet demand and is working closely with the FDA to ensure a smooth release of new batches. This development is crucial for maintaining the supply of EGRIFTA SV® in the U.S. market.

For further insights into TSE:TH stock, check out TipRanks’ Stock Analysis page.